Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,496 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

NCT01211587

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • The Parkinson's Institute Sunnyvale, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

NCT01113320

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Medical University Graz, Klinische Abteilung für Spezielle Neurologie Graz, Austria
  • Medical University Innsbruck, Dept. of Neurology Innsbruck, Austria
  • Quebec Memory and Motor Skills Disorders Québec, Canada
  • Hôpital Roger Sallengro Lille, France
View Trial Details
Completed

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

NCT00627640

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • San Francisco Clinical Research Center San Francisco, California, United States
View all 121 locations
View Trial Details
Completed

Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

NCT01060878

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of California, Irvine Irvine, California, United States
  • Coastal Neurological Medical Group La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 111 locations
View Trial Details
Completed

Embryonic Dopamine Cell Implants for Parkinson's Disease

NCT00038116

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • University Hospital, the University of Colorado Health Sciences Center Denver, Colorado, United States
  • North Shore University Hospital Manhasset, New York, United States
  • The Movement Disorder Center, Columbia-Presbyterian Hospital New York, United States
View Trial Details

Related conditions